Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response in Melanoma or NSCLC Participants
Conditions: Melanoma; Non-Small Cell Lung Cancer Intervention: Drug: Single Arm Sponsors: Cytosite Biopharma Inc.; Massachusetts General Hospital; University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Immunotherapy | Melanoma | Non-Small Cell Lung Cancer | Research | Skin Cancer